Concepedia

Ahong Huang

AH

Statistics

Publications

12

Citations

349

H-Index

11

Active since

2018

Affiliations

STATinMED (United States)(Current)

Duke University

Pfizer (United States)

Astellas Pharma (United States)

Janssen (United States)

Ahong Huang is an author at STATinMED (United States) specializing in medicine, metastatic cancer management, and chemotherapy.

Publications per year

2018–2025

12

Publications

12

Real-world adherence and persistence for newly-prescribed HIV treatment: single versus multiple tablet regimen comparison among US medicaid beneficiaries

Joshua Cohen, Anne Beaubrun, Richa Bashyal et al. · AIDS Research and Therapy · 2020 · 71 citations · Full text

, , +14

Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate

Scott T. Tagawa, Krishnan Ramaswamy, Ahong Huang et al. · Prostate Cancer and Prostatic Diseases · 2021 · 60 citations · Full text

, , +17

Overall survival by race in chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate or enzalutamide.

Megan McNamara, Daniel J. George, Krishnan Ramaswamy et al. · Journal of Clinical Oncology · 2019 · 35 citations

, , +14

Real-world utilization patterns of systemic immunosuppressants among US adult patients with atopic dermatitis

April W. Armstrong, Ahong Huang, Li Wang et al. · PLoS ONE · 2019 · 33 citations · Full text

, , +16

Survival by race in men with chemotherapy-naive enzalutamide- or abiraterone-treated metastatic castration-resistant prostate cancer

Daniel J. George, Krishnan Ramaswamy, Ahong Huang et al. · Prostate Cancer and Prostatic Diseases · 2021 · 32 citations · Full text

, , +15

1–5 of 12